(Q36030264)

11 August 2017

1 reference

title

Recent developments in critical genes in the molecular biology of breast cancer (English)

1 reference

11 August 2017

1 reference

Somkiat Sunpaweravong

series ordinal

1

1 reference

11 August 2017

Patrapim Sunpaweravong

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2005

1 reference

11 August 2017

number of pages

5

1 reference

inferred from page(s)

published in

Asian Journal of Surgery

1 reference

11 August 2017

volume

28

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

71-75

1 reference

Linkage of early-onset familial breast cancer to chromosome 17q21

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Assessing the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Evidence-based management options for women at increased breast/ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Trastuzumab use in breast cancer: clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Risk factors for doxorubicin-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Trastuzumab-associated cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

p53 gene mutation: software and database

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

The UMD-p53 database: new mutations and analysis tools

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

The IARC TP53 database: new online mutation analysis and recommendations to users

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Assessing TP53 status in human tumours to evaluate clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

TP53 and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

Clinical update of Ad-p53 gene therapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1015-9584%2809%2960265-7

7 January 2021

10.1016/S1015-9584(09)60265-7

Identifiers

DOI

0 references

1 reference